As a research tool, BPC-157 does not correspond to any known endogenous receptor ligand but has demonstrated interactions with several signaling systems in preclinical models
For example, you might use upper left abdomen one week, lower left the next, lower right after that, then upper right
Diarrhea Diarrhea is less common than constipation but still affects 5%25% of patients, most often in the first few weeks of therapy
Its kind of like, Yeah, whats the point
At a high level, both oral and injectable Wegovy act as GLP-1 receptor agonists, supporting weight loss through appetite regulation, delayed gastric emptying, and improved satiety
However, glutathione is generally considered safe for most individuals when taken within recommended dosages